{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:26:50Z","timestamp":1792783610957,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007723","name":"Oxford University Press","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The University Challenge Seed Fund"},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Strategic Foundation of Medical Research"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.biomaterials.2020.120435","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T05:35:41Z","timestamp":1601876141000},"page":"120435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle"],"prefix":"10.1016","volume":"266","author":[{"given":"Mariana","family":"Concei\u00e7\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Forcina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar P.B.","family":"Wiklander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel Z.","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besarte","family":"Vrellaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"McClorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"M\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"G\u04e7rgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Musar\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir EL","family":"Andaloussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120435_bib2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120435_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"El Andaloussi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"492","key":"10.1016\/j.biomaterials.2020.120435_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav8521","article-title":"Advances in therapeutic applications of extracellular vesicles","volume":"11","author":"Wiklander","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"6478","key":"10.1016\/j.biomaterials.2020.120435_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120435_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1089\/hum.2015.072","article-title":"Therapeutic potential of multipotent mesenchymal stromal cells and their extracellular vesicles","volume":"26","author":"Heldring","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biomaterials.2020.120435_bib8","doi-asserted-by":"crossref","DOI":"10.21037\/sci.2017.09.06","article-title":"Clinical potential of mesenchymal stem\/stromal cell-derived extracellular vesicles","volume":"4","author":"Giebel","year":"2017","journal-title":"Stem Cell Invest."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/stem.3061","article-title":"Preclinical translation of exosomes derived from mesenchymal stem\/stromal cells","volume":"38","author":"Elahi","year":"2020","journal-title":"Stem Cell."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120435_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.scr.2008.02.002","article-title":"Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium","volume":"1","author":"Timmers","year":"2008","journal-title":"Stem Cell Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120435_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120435_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038746","article-title":"Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease","volume":"7","author":"van Koppen","year":"2012","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120435_bib13","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/nprot.2012.131","article-title":"Exosome-mediated delivery of siRNA in vitro and in vivo","volume":"7","author":"El-Andaloussi","year":"2012","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120435_bib14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ymthe.2017.03.030","article-title":"Engineered exosomes as vehicles for biologically active proteins","volume":"25","author":"Sterzenbach","year":"2017","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib15","doi-asserted-by":"crossref","first-page":"1440131","DOI":"10.1080\/20013078.2018.1440131","article-title":"Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery","volume":"7","author":"Yang","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biomaterials.2020.120435_bib16","doi-asserted-by":"crossref","first-page":"119826","DOI":"10.1016\/j.biomaterials.2020.119826","article-title":"Effects of exosome-mediated delivery of myostatin propeptide on functional recovery of mdx mice","volume":"236","author":"Ran","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2020.120435_bib17","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.2147\/IJN.S196975","article-title":"Decoy exosomes as a novel biologic reagent to antagonize inflammation","volume":"14","author":"Duong","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2020.120435_bib18","first-page":"2020","article-title":"Engineering of extracellular vesicles for display of protein biotherapeutics","author":"Gupta","year":"2020","journal-title":"bioRxiv"},{"issue":"6469","key":"10.1016\/j.biomaterials.2020.120435_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","article-title":"Impaired immune and acute-phase responses in interleukin-6-deficient mice","volume":"368","author":"Kopf","year":"1994","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120435_bib20","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni.3632","article-title":"Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells","volume":"18","author":"Heink","year":"2017","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fj.99-1003rev","article-title":"The soluble interleukin 6 receptor: mechanisms of production and implications in disease","volume":"15","author":"Jones","year":"2001","journal-title":"Faseb. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.smim.2013.11.002","article-title":"Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities","volume":"26","author":"Scheller","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biomaterials.2020.120435_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2018.05.001","article-title":"The physiopathologic interplay between stem cells and tissue niche in muscle regeneration and the role of IL-6 on muscle homeostasis and diseases","volume":"41","author":"Forcina","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120435_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nbt0297-142","article-title":"A bioactive designer cytokine for human hematopoietic progenitor cell expansion","volume":"15","author":"Fischer","year":"1997","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120435_bib26","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.149.6.2021","article-title":"Complex of soluble human IL-6-receptor\/IL-6 up-regulates expression of acute-phase proteins","volume":"149","author":"Mackiewicz","year":"1992","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","article-title":"Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses","volume":"268","author":"Jostock","year":"2001","journal-title":"Eur. J. Biochem."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120435_bib28","first-page":"755","article-title":"Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention","volume":"1","author":"Evans","year":"2009","journal-title":"Pharm. Manag. PM R"},{"key":"10.1016\/j.biomaterials.2020.120435_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/540370","article-title":"Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy","volume":"2013","author":"De Paepe","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120435_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib31","article-title":"Duchenne muscular dystrophy","volume":"24","author":"Emery","year":"1988","journal-title":"Ann. Neurol."},{"issue":"9307","key":"10.1016\/j.biomaterials.2020.120435_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120435_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0959-437X(02)00309-X","article-title":"Muscular dystrophies involving the dystrophin\u2013glycoprotein complex: an overview of current mouse models","volume":"12","author":"Durbeej","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"299","key":"10.1016\/j.biomaterials.2020.120435_bib34","doi-asserted-by":"crossref","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/jfmk2040044","article-title":"Insights into the pathogenic secondary symptoms caused by the primary loss of dystrophin","volume":"2","author":"Forcina","year":"2017","journal-title":"J. Funct. Morphol. Kinesiol."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120435_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2174\/1389202919666180101153911","article-title":"Molecular insights into muscle homeostasis, atrophy and wasting","volume":"19","author":"Scicchitano","year":"2018","journal-title":"Curr. Genom."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120435_bib37","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1177\/0883073810371004","article-title":"Change in natural history of duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management","volume":"25","author":"Moxley","year":"2010","journal-title":"J. Child Neurol."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120435_bib38","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S1474-4422(16)30035-7","article-title":"Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy","volume":"15","author":"Straub","year":"2016","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170259","article-title":"Systematic review of the toxicity of long-course oral corticosteroids in children","volume":"12","author":"Aljebab","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.biomaterials.2020.120435_bib40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phrs.2018.09.007","article-title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","volume":"136","author":"Conklin","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JND-180341","article-title":"Phase 1 study of edasalonexent (CAT-1004), an oral NF-\u03baB inhibitor, in pediatric patients with duchenne muscular dystrophy","volume":"6","author":"Finanger","year":"2019","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.biomaterials.2020.120435_bib42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3181\/00379727-205-43695","article-title":"Interleukin-6 induces skeletal muscle protein breakdown in rats","volume":"205","author":"Goodman","year":"1994","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/bbrc.1995.1168","article-title":"Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse","volume":"207","author":"Tsujinaka","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120435_bib44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","article-title":"IL-6-induced skeletal muscle atrophy","volume":"98","author":"Haddad","year":"2005","journal-title":"J. Appl. Physiol."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120435_bib45","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/nm.3655","article-title":"Inhibition of JAK-STAT signaling stimulates adult satellite cell function","volume":"20","author":"Price","year":"2014","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120435_bib46","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/nm.3656","article-title":"STAT3 signaling controls satellite cell expansion and skeletal muscle repair","volume":"20","author":"Tierney","year":"2014","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120435_bib47","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metabol."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120435_bib48","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/jbmr.410","article-title":"Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans","volume":"26","author":"Rufo","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ebiom.2015.02.014","article-title":"Functional and morphological improvement of dystrophic muscle by interleukin 6 receptor blockade","volume":"2","author":"Pelosi","year":"2015","journal-title":"EBioMedicine"},{"issue":"21","key":"10.1016\/j.biomaterials.2020.120435_bib50","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1093\/hmg\/ddv323","article-title":"Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice","volume":"24","author":"Pelosi","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120435_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.4231","article-title":"Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice","volume":"231","author":"Huynh","year":"2013","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13395-017-0140-z","article-title":"Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-\/utrophin-deficient mice","volume":"7","author":"Wada","year":"2017","journal-title":"Skeletal Muscle"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120435_bib53","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2141.2003.04217.x","article-title":"Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase","volume":"120","author":"Mihara","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biomaterials.2020.120435_bib54","series-title":"Adult Stem Cells: Methods and Protocols","first-page":"155","article-title":"Isolation and culture of satellite cells from mouse skeletal muscle","author":"Musar\u00f2","year":"2017"},{"issue":"Pt 10","key":"10.1016\/j.biomaterials.2020.120435_bib55","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1107\/S0907444906029799","article-title":"A time- and cost-efficient system for high-level protein production in mammalian cells","volume":"62","author":"Aricescu","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib56","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.nano.2015.01.003","article-title":"Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties","volume":"11","author":"Nordin","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120435_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib58","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1038\/s41598-017-06483-7","article-title":"BRD3 and BRD4 BET bromodomain proteins differentially regulate skeletal myogenesis","volume":"7","author":"Roberts","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120435_bib59","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood.V92.10.3495","article-title":"Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis","volume":"92","author":"Peters","year":"1998","journal-title":"Blood"},{"issue":"Pt 2","key":"10.1016\/j.biomaterials.2020.120435_bib60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"issue":"22","key":"10.1016\/j.biomaterials.2020.120435_bib61","doi-asserted-by":"crossref","first-page":"12999","DOI":"10.1074\/jbc.271.22.12999","article-title":"Differential activation of acute phase response factor\/stat3 and Stat 1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130: II. Src homology SH2 domains define the specificity OF STAT factor activation","volume":"271","author":"Hemmann","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-Deficient mice as a model for duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120435_bib63","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fj.06-7353com","article-title":"Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma","volume":"21","author":"Chamberlain","year":"2007","journal-title":"Faseb. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00687043","article-title":"Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse","volume":"69","author":"Tanabe","year":"1986","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120435_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0022-510X(93)90130-Q","article-title":"Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies","volume":"119","author":"McGeachie","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biomaterials.2020.120435_bib66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/hmg\/11.3.263","article-title":"A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice","volume":"11","author":"Porter","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120435_bib67","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/hmg\/dds082","article-title":"Rescue of severely affected dystrophin\/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping","volume":"21","author":"Goyenvalle","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib68","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.nmd.2008.02.002","article-title":"Mdx respiratory impairment following fibrosis of the diaphragm","volume":"18","author":"Ishizaki","year":"2008","journal-title":"Neuromuscul. Disord."},{"issue":"43","key":"10.1016\/j.biomaterials.2020.120435_bib69","doi-asserted-by":"crossref","first-page":"26059","DOI":"10.1074\/jbc.M115.649509","article-title":"Shedding of endogenous interleukin-6 receptor (IL-6R) is governed by A Disintegrin and metalloproteinase (ADAM) proteases while a full-length IL-6R isoform localizes to circulating microvesicles","volume":"290","author":"Schumacher","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120435_bib70","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0092-8674(05)80070-4","article-title":"The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex","volume":"71","author":"Ellenberger","year":"1992","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120435_bib71","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pbio.0050158","article-title":"Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes","volume":"5","author":"Fang","year":"2007","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120435_bib72","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncb2502","article-title":"Syndecan\u2013syntenin\u2013ALIX regulates the biogenesis of exosomes","volume":"14","author":"Baietti","year":"2012","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib73","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jmb.2015.09.019","article-title":"ExoCarta: a web-based compendium of exosomal cargo","volume":"428","author":"Keerthikumar","year":"2016","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120435_bib74","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation","volume":"8","author":"Gabay","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120435_bib75","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1172\/JCI57158","article-title":"Therapeutic strategies for the clinical blockade of IL-6\/gp130 signaling","volume":"121","author":"Jones","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120435_bib76","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2005.06.035","article-title":"Monoclonal antibodies and fusion proteins in medicine","volume":"116","author":"Liossis","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120435_bib77","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1471-4906(01)01941-X","article-title":"Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines","volume":"22","author":"Mantovani","year":"2001","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120435_bib78","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.copbio.2009.10.010","article-title":"Receptor-Fc fusion therapeutics, traps, and MIMETIBODY\u2122 technology","volume":"20","author":"Huang","year":"2009","journal-title":"Curr. Opin. Biotechnol."},{"issue":"37","key":"10.1016\/j.biomaterials.2020.120435_bib79","doi-asserted-by":"crossref","first-page":"15336","DOI":"10.1073\/pnas.1102855108","article-title":"Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3","volume":"108","author":"Aung","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120435_bib80","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcp.22773","article-title":"Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy","volume":"227","author":"Ciravolo","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120435_bib81","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41467-018-08109-6","article-title":"Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity","volume":"10","author":"Capello","year":"2019","journal-title":"Nat. Commun."},{"issue":"7798","key":"10.1016\/j.biomaterials.2020.120435_bib82","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41586-020-2066-6","article-title":"Decoy exosomes provide protection against bacterial toxins","volume":"579","author":"Keller","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2020.120435_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/206026","article-title":"IL-6 impairs myogenic differentiation by downmodulation of p90RSK\/eEF2 and mTOR\/p70S6K axes, without affecting AKT activity","volume":"2014","author":"Pelosi","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120435_bib84","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2014.63","article-title":"Effective dystrophin restoration by a novel muscle-homing peptide\u2013morpholino conjugate in dystrophin-deficient mdx mice","volume":"22","author":"Gao","year":"2014","journal-title":"Mol. Ther."},{"issue":"444","key":"10.1016\/j.biomaterials.2020.120435_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0195","article-title":"Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy","volume":"10","author":"Gao","year":"2018","journal-title":"Sci. Transl. Med."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220306815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220306815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:55:37Z","timestamp":1758905737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961220306815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":85,"alternative-id":["S0142961220306815"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120435","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.09.142216","asserted-by":"object"}]},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120435"}}